These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8456497)

  • 1. Single-lung versus liver transplantation for the treatment of portopulmonary hypertension--a comparison of two patients.
    Yoshida EM; Erb SR; Pflugfelder PW; Ostrow DN; Ricci DR; Ghent CN; Wall WJ; Grant D; Scudamore CH; Shackleton CB
    Transplantation; 1993 Mar; 55(3):688-90. PubMed ID: 8456497
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol.
    Tan HP; Markowitz JS; Montgomery RA; Merritt WT; Klein AS; Thuluvath PJ; Poordad FF; Maley WR; Winters B; Akinci SB; Gaine SP
    Liver Transpl; 2001 Aug; 7(8):745-9. PubMed ID: 11510023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era.
    Mandell MS
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S54-8. PubMed ID: 15382220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model for end-stage liver disease (MELD) exception for portopulmonary hypertension.
    Krowka MJ; Fallon MB; Mulligan DC; Gish RG
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S114-6. PubMed ID: 17123283
    [No Abstract]   [Full Text] [Related]  

  • 5. Recurrent portopulmonary hypertension after liver transplantation: management with epoprostenol and resolution after retransplantation.
    Kett DH; Acosta RC; Campos MA; Rodriguez MJ; Quartin AA; Schein RM
    Liver Transpl; 2001 Jul; 7(7):645-8. PubMed ID: 11460234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portopulmonary hypertension.
    Passarella M; Fallon MB; Kawut SM
    Clin Liver Dis; 2006 Aug; 10(3):653-63, x. PubMed ID: 17162233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation.
    Krowka MJ
    Clin Chest Med; 2005 Dec; 26(4):587-97, vi. PubMed ID: 16263398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epoprostenol in the treatment of portopulmonary hypertension].
    Culafić D; Culafić-Vojinović V; Jesić R
    Srp Arh Celok Lek; 2003; 131(5-6):271-4. PubMed ID: 14692137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portopulmonary hypertension and hepatopulmonary syndrome, and liver transplantation.
    Ramsay MA
    Int Anesthesiol Clin; 2006; 44(3):69-82. PubMed ID: 16832207
    [No Abstract]   [Full Text] [Related]  

  • 10. Portopulmonary hypertension as an indication for combined heart, lung, and liver or lung and liver transplantation: literature review and case presentation.
    Scouras NE; Matsusaki T; Boucek CD; Wells C; Cooper EA; Planinsic RM; Sullivan EA; Bermudez CA; Toyoda Y; Sakai T
    Liver Transpl; 2011 Feb; 17(2):137-43. PubMed ID: 21280186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Perioperative management of living-donor liver transplantation in two patients with severe portopulmonary hypertension].
    Tominaga M; Furutani H; Segawa H; Shoda T; Mima H; Adachi T; Fukuda K
    Masui; 2003 Jul; 52(7):729-32. PubMed ID: 12910972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portopulmonary hypertension and the issue of survival.
    Krowka MJ
    Liver Transpl; 2005 Sep; 11(9):1026-7. PubMed ID: 16123957
    [No Abstract]   [Full Text] [Related]  

  • 13. Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension.
    Findlay JY; Plevak DJ; Krowka MJ; Sack EM; Porayko MK
    Liver Transpl Surg; 1999 Sep; 5(5):362-5. PubMed ID: 10477835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.
    Fix OK; Bass NM; De Marco T; Merriman RB
    Liver Transpl; 2007 Jun; 13(6):875-85. PubMed ID: 17539008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation.
    Krowka MJ; Plevak DJ; Findlay JY; Rosen CB; Wiesner RH; Krom RA
    Liver Transpl; 2000 Jul; 6(4):443-50. PubMed ID: 10915166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension.
    Krowka MJ; Frantz RP; McGoon MD; Severson C; Plevak DJ; Wiesner RH
    Hepatology; 1999 Sep; 30(3):641-8. PubMed ID: 10462369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.
    Kähler CM; Graziadei I; Wiedermann CJ; Kneussl MP; Vogel W
    Wien Klin Wochenschr; 2000 Jul; 112(14):637-40. PubMed ID: 11008327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What might be learned from acute pulmonary vasodilator testing in portopulmonary hypertension?
    Swanson KL
    Liver Transpl; 2007 Nov; 13(11):1498-9. PubMed ID: 17969195
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension.
    Plotkin JS; Kuo PC; Rubin LJ; Gaine S; Howell CD; Laurin J; Njoku MJ; Lim JW; Johnson LB
    Transplantation; 1998 Feb; 65(4):457-9. PubMed ID: 9500616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database.
    Krowka MJ; Mandell MS; Ramsay MA; Kawut SM; Fallon MB; Manzarbeitia C; Pardo M; Marotta P; Uemoto S; Stoffel MP; Benson JT
    Liver Transpl; 2004 Feb; 10(2):174-82. PubMed ID: 14762853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.